These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15474444)

  • 1. Trends in breast cancer presentation and care according to age in a single institution.
    Agnese DM; Yusuf F; Wilson JL; Shapiro CL; Lehman A; Burak WE
    Am J Surg; 2004 Oct; 188(4):437-9. PubMed ID: 15474444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study.
    Hartley MC; McKinley BP; Rogers EA; Kalbaugh CA; Messich HS; Blackhurst DW; Lokey JS; Trocha SD
    Am Surg; 2006 Dec; 72(12):1189-94; discussion 1194-5. PubMed ID: 17216817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do very young Korean breast cancer patients have worse outcomes?
    Kim JK; Kwak BS; Lee JS; Hong SJ; Kim HJ; Son BH; Ahn SH
    Ann Surg Oncol; 2007 Dec; 14(12):3385-91. PubMed ID: 17899295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Young age influences treatment but not outcome of colon cancer.
    Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of clinical and pathological features of breast cancer in women with 40 years old and younger vs 70 years old and older].
    Cuan Martínez JR; Mainero Ratchelous FE; Aguilar Gallegos IU; Bernechea Miranda A; Buenrostro Pineda MA; Burgos Portillo I; Cortés Herrera AE; Burguete Vera JJ
    Ginecol Obstet Mex; 2008 Jun; 76(6):299-306. PubMed ID: 18800585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.
    Gennari R; Curigliano G; Rotmensz N; Robertson C; Colleoni M; Zurrida S; Nolè F; de Braud F; Orlando L; Leonardi MC; Galimberti V; Intra M; Veronesi P; Renne G; Cinieri S; Audisio RA; Luini A; Orecchia R; Viale G; Goldhirsch A
    Cancer; 2004 Sep; 101(6):1302-10. PubMed ID: 15316944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and outcomes of adjuvant chemotherapy in older women with breast cancer.
    Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Goodwin JS
    J Clin Oncol; 2006 Jun; 24(18):2750-6. PubMed ID: 16782915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.
    Ahn SH; Son BH; Kim SW; Kim SI; Jeong J; Ko SS; Han W;
    J Clin Oncol; 2007 Jun; 25(17):2360-8. PubMed ID: 17515570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
    J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
    Fisher B; Jeong JH; Anderson S; Wolmark N
    J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
    Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
    Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
    Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting.
    Hawfield A; Lovato J; Covington D; Kimmick G
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):250-5. PubMed ID: 16527489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.